Planned withdrawal of dexamethasone after pomalidomide low-dose dexamethasone induction for lenalidomide-refractory multiple myeloma (ALLG MM14).
作者信息
Kalff Anna, Khong Tiffany, Ramachandran Malarmathy, Ho P Joy, Mollee Peter, D'Rozario James, Taylor Kerry, Estell Jane, Norton Sam, Kemp Roslyn, Mitchell Andrew J, Reynolds John, Kennedy Nola, Quach Hang, Spencer Andrew
机构信息
Malignant Haematology and Stem Cell Transplantation, Alfred Hospital, Melbourne, Victoria, Australia; Myeloma Research Group, Australian Centre for Blood Diseases, Alfred Hospital-Monash University, Melbourne, Victoria, Australia; Department of Clinical Haematology, Monash University, Clayton, Victoria.
Malignant Haematology and Stem Cell Transplantation, Alfred Hospital, Melbourne, Victoria, Australia; Myeloma Research Group, Australian Centre for Blood Diseases, Alfred Hospital-Monash University, Melbourne, Victoria.
出版信息
Haematologica. 2022 Jan 1;107(1):321-325. doi: 10.3324/haematol.2021.278655.
Zotero 插件